Medical Devices Reimbursement Market Report 2026

The medical devices reimbursement market size has grown strongly in recent years. It will grow from $648.71 billion in 2025 to $706.49 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to growth in medical device adoption, expansion of public health insurance programs, rising healthcare expenditure, increased use of advanced medical devices, development of standardized billing codes.

The medical devices reimbursement market size is expected to see strong growth in the next few years. It will grow to $998.61 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increase in innovative and high-cost devices, growing payer scrutiny on cost effectiveness, expansion of outpatient care settings, rising demand for reimbursement transparency, evolution of reimbursement policy frameworks. Major trends in the forecast period include shift toward value-based reimbursement models, increasing complexity of reimbursement pathways, rising importance of clinical and economic evidence, growing focus on faster coverage decisions, expansion of reimbursement support services.

The increasing demand for minimally invasive surgeries is anticipated to drive the growth of the medical device reimbursement market in the coming years. Minimally invasive surgery (MIS) is a medical technique that employs specialized instruments and methods to carry out surgical procedures with minimal disruption to the patient’s body compared to conventional open surgery. The advantages of medical device reimbursement for minimally invasive surgery include enhanced patient access to advanced treatments and lower healthcare costs due to shorter hospital stays. For example, in September 2023, according to the American Society of Plastic Surgeons (ASPS), a US-based plastic surgery specialty organization, 4,715,716 minimally invasive procedures were performed using botulinum toxin type A (including Botox, Dysport, and Xeomin) in 2023, marking a 6% rise from the previous year. Dermal fillers also experienced substantial utilization, with 3,441,534 procedures conducted, up 4% from 2022. Consequently, the rising demand for minimally invasive surgeries is propelling the growth of the medical device reimbursement market.

Major companies in the medical device reimbursement market are emphasizing the development of technological innovations such as electronic medical records (EMR) to maintain their market position. Electronic medical records (EMRs) are digital counterparts of a patient’s paper medical charts, used to support reimbursement claims by ensuring that devices are medically necessary and appropriately utilized. For example, in April 2023, Wemex Corporation, a Japan-based IT solutions provider, introduced the medicom-HRf hybrid cloud, an integrated electronic medical record (EMR) system leveraging cloud technology to enable location-independent operations for clinics. Hybrid cloud solutions like Medicom-HRf can seamlessly consolidate multiple data sources, including patient records, medical billing, insurance claims, and regulatory information. This consolidation delivers a comprehensive view of patient treatment and billing history, essential for accurate reimbursement. Medical device companies can access real-time information on insurance coverage, reimbursement rates, and claim status.

In January 2025, Klick Health Inc., a Canada-based healthcare marketing and technology company, acquired Peregrine Market Access Inc. for an undisclosed sum. Through this acquisition, Klick Health Inc. seeks to enhance its market-access capabilities and strengthen client solutions by integrating Peregrine Market Access Inc.’s expertise in pricing, reimbursement, and health economics, thereby improving market-entry strategies for pharmaceutical and biotech clients. Peregrine Market Access Inc. is a Canada-based healthcare consultancy specializing in market-access strategy, health economics, and reimbursement solutions for life sciences companies.

Major companies operating in the medical devices reimbursement market are UnitedHealth Group, CVS Health Corporation, Cigna Corporation, Anthem Insurance Companies Inc., Aetna Inc., Humana Inc., WellCare Health Plans Inc., Reliance Nippon Life Insurance Company Limited, Axa S.A., Assicurazioni Generali SpA, Allianz SE, Zurich Insurance Group Ltd., Aviva plc, Aegon Life Insurance Company, Munich Re Group, Kaiser Permanente, Centene Corporation, Bupa Group, Molina Healthcare, HCSC Health Care Service Corporation, Ping An Insurance Group, China Life Insurance Company, Oscar Health, Medibank Private Limited, Discovery Health Limited.

North America was the largest region in the medical devices reimbursement market in 2025. The regions covered in the medical devices reimbursement market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical devices reimbursement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs impact the medical devices reimbursement market by increasing device costs, which can influence payer coverage decisions and reimbursement rates. Regions such as north america, europe, and asia-pacific are most affected due to cross-border device sourcing. Higher tariffs may delay reimbursement approvals or reduce coverage levels. However, they can also encourage local manufacturing, supporting more predictable pricing and reimbursement negotiations.

The medical devices reimbursement market research report is one of a series of new reports that provides medical devices reimbursement market statistics, including medical devices reimbursement industry global market size, regional shares, competitors with a medical devices reimbursement market share, detailed medical devices reimbursement market segments, market trends and opportunities, and any further data you may need to thrive in the medical devices reimbursement industry. This medical devices reimbursement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical device reimbursement is the process through which insurance plans or payers compensate healthcare providers for supplying medically necessary devices to patients. This process includes determining the device’s cost, assessing its effectiveness, and negotiating with payers to ensure insurance coverage.

The primary payers of medical device reimbursement are public and private. A public payer is a government-funded organization or entity responsible for funding and managing healthcare services for a specific population or country. Hospitals, outpatient facilities, and other healthcare settings submit claims for underpaid or full amounts.

The medical devices reimbursement market includes revenues earned by entities by providing services such as coding and billing services, claims processing, coverage determination, benefit verification, coding and billing training, and pre-authorization and pre-certification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.